生物刺激的芝麻芽提取物作为潜在的抗莱什马尼亚墨西哥菌的药物
Karime G Garduño-Félix1, Jesús J Rochín-Medina1, Carolina C Murua-López2
1Laboratorio de Microbiología Molecular y Bioactivos, Tecnológico Nacional de México-Instituto Tecnológico de Culiacán, 80220 Culiacán, México.
Letters in applied microbiology
|October 1, 2023
概括
由Bacillus clausii增强的黑芝麻芽含有类化合物,显示出强大的leishmanicidal活性. 这些天然化合物为皮肤莱什曼病的当前治疗提供了一个有希望的,少有毒的替代方案.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品化学 自然产品化学
- 寄生虫学的寄生虫学
背景情况:
- 皮肤雷什曼病是由墨西哥雷什曼病引起的,由于目前药物的不良影响,需要新的治疗方法.
- 用Bacillus clausii生物刺激的黑芝麻芽含有丰富的化合物,具有潜在的治疗特性.
研究的目的:
- 评估生物刺激黑芝麻芽中的类化合物对墨西哥菌的杀虫潜力.
- 研究这些天然化合物的分子相互作用和体外疗效.
主要方法:
- 在的分子对接被用来分析化合物和关键的莱什曼酶之间的相互作用.
- 在体外试验中,评估了在巨细胞感染模型中的Leishmania mexicana前子生长和影响的抑制.
主要成果:
- 像阿皮根因这样的化合物显示出强烈的结合于莱什曼酶 (阿基纳,莱什曼诺林素,氨酸酶B,酸盐激酶).
- 生物刺激的芽苗提取物和apigenin显示出显著抑制前列腺细胞生长 (提供IC50值).
- 治疗减少了氧化的产生和感染巨细胞中的寄生虫负担.
结论:
- 来自Bacillus clausii生物刺激的黑芝麻芽的类化合物对墨西哥莱什马尼亚有很高的疗效.
- 这些天然化合物代表了开发新型抗莱什曼治疗的有希望的,少毒的候选人.
更多相关视频
10:01Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites
Published on: March 16, 2018
10.6K
06:57In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.3K
相关概念视频
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
